These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 24985407)

  • 1. Metformin and cancer risk and mortality: a systematic review and meta-analysis taking into account biases and confounders.
    Gandini S; Puntoni M; Heckman-Stoddard BM; Dunn BK; Ford L; DeCensi A; Szabo E
    Cancer Prev Res (Phila); 2014 Sep; 7(9):867-85. PubMed ID: 24985407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis.
    Decensi A; Puntoni M; Goodwin P; Cazzaniga M; Gennari A; Bonanni B; Gandini S
    Cancer Prev Res (Phila); 2010 Nov; 3(11):1451-61. PubMed ID: 20947488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer risk in diabetic patients treated with metformin: a systematic review and meta-analysis.
    Noto H; Goto A; Tsujimoto T; Noda M
    PLoS One; 2012; 7(3):e33411. PubMed ID: 22448244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Metformin with Breast Cancer Incidence and Mortality in Patients with Type II Diabetes: A GRADE-Assessed Systematic Review and Meta-analysis.
    Tang GH; Satkunam M; Pond GR; Steinberg GR; Blandino G; Schünemann HJ; Muti P
    Cancer Epidemiol Biomarkers Prev; 2018 Jun; 27(6):627-635. PubMed ID: 29618465
    [No Abstract]   [Full Text] [Related]  

  • 5. Association of metformin use with cancer incidence and mortality: a meta-analysis.
    Zhang P; Li H; Tan X; Chen L; Wang S
    Cancer Epidemiol; 2013 Jun; 37(3):207-18. PubMed ID: 23352629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin and breast cancer risk: a meta-analysis and critical literature review.
    Col NF; Ochs L; Springmann V; Aragaki AK; Chlebowski RT
    Breast Cancer Res Treat; 2012 Oct; 135(3):639-46. PubMed ID: 22847511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulphonylurea monotherapy for patients with type 2 diabetes mellitus.
    Hemmingsen B; Schroll JB; Lund SS; Wetterslev J; Gluud C; Vaag A; Sonne DP; Lundstrøm LH; Almdal T
    Cochrane Database Syst Rev; 2013 Apr; (4):CD009008. PubMed ID: 23633364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of metformin on mortality following cancer among patients with diabetes.
    Lega IC; Shah PS; Margel D; Beyene J; Rochon PA; Lipscombe LL
    Cancer Epidemiol Biomarkers Prev; 2014 Oct; 23(10):1974-84. PubMed ID: 25030683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin is associated with reduced risk of pancreatic cancer in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.
    Wang Z; Lai ST; Xie L; Zhao JD; Ma NY; Zhu J; Ren ZG; Jiang GL
    Diabetes Res Clin Pract; 2014 Oct; 106(1):19-26. PubMed ID: 24837144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of metformin use and cancer incidence: a systematic review and meta-analysis.
    O'Connor L; Bailey-Whyte M; Bhattacharya M; Butera G; Hardell KNL; Seidenberg AB; Castle PE; Loomans-Kropp HA
    J Natl Cancer Inst; 2024 Apr; 116(4):518-529. PubMed ID: 38291943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin Is Associated With Slightly Reduced Risk of Colorectal Cancer and Moderate Survival Benefits in Diabetes Mellitus: A Meta-Analysis.
    He XK; Su TT; Si JM; Sun LM
    Medicine (Baltimore); 2016 Feb; 95(7):e2749. PubMed ID: 26886616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular risk associated with the use of glitazones, metformin and sufonylureas: meta-analysis of published observational studies.
    Pladevall M; Riera-Guardia N; Margulis AV; Varas-Lorenzo C; Calingaert B; Perez-Gutthann S
    BMC Cardiovasc Disord; 2016 Jan; 16():14. PubMed ID: 26769243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review and meta-analysis of the effect of metformin treatment on overall mortality rates in women with endometrial cancer and type 2 diabetes mellitus.
    Perez-Lopez FR; Pasupuleti V; Gianuzzi X; Palma-Ardiles G; Hernandez-Fernandez W; Hernandez AV
    Maturitas; 2017 Jul; 101():6-11. PubMed ID: 28539171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin Use and Lung Cancer Risk in Diabetic Patients: A Systematic Review and Meta-Analysis.
    Yao L; Liu M; Huang Y; Wu K; Huang X; Zhao Y; He W; Zhang R
    Dis Markers; 2019; 2019():6230162. PubMed ID: 30881522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin and thyroid carcinoma incidence and prognosis: A systematic review and meta-analysis.
    Wang Z; Luo J; Zhang Y; Xun P; Chen Z
    PLoS One; 2022; 17(7):e0271038. PubMed ID: 35901016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidiabetic Medications and the Risk of Endometrial Cancer in Patients.
    Tian J; Liang Y; Qu P
    Gynecol Obstet Invest; 2019; 84(5):455-462. PubMed ID: 30808843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of metformin intake with bladder cancer risk and oncologic outcomes in type 2 diabetes mellitus patients: A systematic review and meta-analysis.
    Hu J; Chen JB; Cui Y; Zhu YW; Ren WB; Zhou X; Liu LF; Chen HQ; Zu XB
    Medicine (Baltimore); 2018 Jul; 97(30):e11596. PubMed ID: 30045293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between the use of metformin and the risk of pancreatic cancer in patients with diabetes: a systematic review and meta-analysis.
    Hu J; Fan HD; Gong JP; Mao QS
    BMC Gastroenterol; 2023 Feb; 23(1):50. PubMed ID: 36829129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin use improves survival of diabetic liver cancer patients: systematic review and meta-analysis.
    Ma SJ; Zheng YX; Zhou PC; Xiao YN; Tan HZ
    Oncotarget; 2016 Oct; 7(40):66202-66211. PubMed ID: 27494848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-diabetic medications and the risk of hepatocellular cancer: a systematic review and meta-analysis.
    Singh S; Singh PP; Singh AG; Murad MH; Sanchez W
    Am J Gastroenterol; 2013 Jun; 108(6):881-91; quiz 892. PubMed ID: 23381014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.